版本:
中国

BRIEF-Adamis Pharmaceuticals gets FDA approval for co's epinephrine pre-filled syringe

June 15 Adamis Pharmaceuticals Corp:

* Adamis pharmaceuticals receives FDA approval for its epinephrine pre-filled syringe

* Adamis pharmaceuticals receives FDA approval for its epinephrine pre-filled syringe

* FDA has also approved PFS trade name of Symjepi

* ‍FDA approved Adamis' epinephrine injection, USP, 1:1000 for emergency treatment of allergic reactions including anaphylaxis​

* Are preparing to submit second NDA for junior version of Symjepi to FDA

* Expect to build inventory levels in preparation for anticipated launch in H2 of year for co's epinephrine pre-filled syringe Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐